(VIANEWS) – Shares of Sorrento Therapeutics (NASDAQ: SRNE) slid by a staggering 16.22% in 5 sessions from $0.37 at -16.22, to $0.31 at 23:23 EST on Wednesday, after five sequential sessions in a row of losses. NASDAQ is falling 0.85% to $11,929.34, after three sequential sessions in a row of losses.
Sorrento Therapeutics’s last close was $0.35, 88.82% below its 52-week high of $3.09.
About Sorrento Therapeutics
Earnings Per Share
As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -378.92%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Sorrento Therapeutics’s stock is considered to be overbought (>=80).
Moving Average
Sorrento Therapeutics’s value is way below its 50-day moving average of $0.77 and way below its 200-day moving average of $1.55.
Sales Growth
Sorrento Therapeutics’s sales growth is 32.2% for the present quarter and 8.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth grew by 44.3%, now sitting on 60.32M for the twelve trailing months.
More news about Sorrento Therapeutics (SRNE).
